Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 6/20 | 0.68 |
| ▸ | CTSK | P43235 | 5/20 | 0.68 |
| ▸ | CTSB | P07858 | 2/20 | 0.68 |
| ▸ | CTSL | P07711 | 1/20 | 0.68 |
| ▸ | ACE | P12821 | 1/20 | 0.65 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.63 |
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | AKT1 | P31749 | 1/20 | 0.59 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.58 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | PPARA | Q07869 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | MMP1 | P03956 | 1/20 | 0.56 |
| ▸ | MMP3 | P08254 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16459753 | 1.00 | CTSS (0.68) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL18435382 | 1.00 | CTSS (0.68) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL18610659 | 0.93 | CTSS (0.70) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL6292728 | 0.93 | KLK5 (0.72) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL7431604 | 0.93 | CTSS (0.67) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL1196457 | 0.93 | KLK5 (0.72) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL84524 | 0.93 | KLK5 (0.72) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL9479971 | 0.93 | CTSS (0.67) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL21473748 | 0.93 | KLK5 (0.72) | CTSSCTSKCTSBCTSLACE | |
| SCHEMBL19485480 | 0.90 | CTSK (0.62) | CTSSCTSKCTSBCTSLPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105175364-B | A kind of method for preparing anti-aids drug amprenavir intermediate | 上海应用技术学院 | 2018-05-22 | — | — | CN | claimed |
| CN-105051008-B | Guanidinobenzoic acid ester compounds | 武田药品工业株式会社 | 2018-05-29 | — | — | CN | disclosed |
| CN-105175364-B | A kind of method for preparing anti-aids drug amprenavir intermediate | 上海应用技术学院 | 2018-05-22 | — | — | CN | disclosed |
| US-20140012005-A1 | PROCESS FOR PREPARING CHIRAL AMINO ACIDS | DIVERCHIM (FR) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012005-A1 | PROCESS FOR PREPARING CHIRAL AMINO ACIDS | BCAT1, DNPEP, BCAT2 | CTSS 724/4885CTSK 2248/4885CTSB 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.